Design, synthesis and biological evaluation of benzo[1.3.2]dithiazolium ylide 1,1-dioxide derivatives as potential dual cyclooxygenase-2/5-lipoxygenase inhibitors
Authors:
- Grace Shiahuy ChenGCGrace Shiahuy Chen
- Chien-Shu ChenCCChien-Shu Chen
- Pei-Teh ChangPCPei-Teh Chang
- Ji-Wang ChernJCJi-Wang Chern
- 1 November 2011
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 19 (21) , 6316-6328
Abstract
No abstract availableKeywords
Funding Information
- National Science Council of the Republic of China (NSC95-2320-B002-035, NSC96-2320-B002-017)
This publication has 25 references indexed in Scilit:
- 5-Lipoxygenase, Leukotrienes Biosynthesis and Potential Antileukotrienic AgentsCurrent Medicinal Chemistry, 2006
- Selective cyclooxygenase 2 inhibitors and cardiovascular eventsArthritis & Rheumatism, 2005
- Adverse Cardiovascular Effects of the CoxibsJournal of Medicinal Chemistry, 2005
- Isomeric acetoxy analogues of rofecoxib: A novel class of highly potent and selective cyclooxygenase-2 inhibitorsBioorganic & Medicinal Chemistry Letters, 2002
- Synthesis and Activity of a New Methoxytetrahydropyran Derivative as Dual Cyclooxygenase-2/5-Lipoxygenase InhibitorBioorganic & Medicinal Chemistry Letters, 2002
- Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2Proceedings of the National Academy of Sciences, 1999
- Cyclooxygenase-1 and Cyclooxygenase-2 Selectivity of Widely Used Nonsteroidal Anti-Inflammatory DrugsThe American Journal of Medicine, 1998
- Recently reported inhibitors of cyclooxygenase-2Expert Opinion on Therapeutic Patents, 1998
- Synthesis and Biological Evaluation of the 1,5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors: Identification of 4-[5-(4-Methylphenyl)-3- (trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib)Journal of Medicinal Chemistry, 1997
- Human cyclooxygenase-2 cDNA.Proceedings of the National Academy of Sciences, 1992